World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
72
Citations
22248
World Ranking
19794
National Ranking
9857

Overview

Edward H. Giannini is affiliated with Cincinnati Children's Hospital Medical Center in the United States. Their research spans multiple fields within medicine, with a strong focus on immunology and microbiology. They have contributed extensively to subfields including immunology, oncology, pathology and forensic medicine, epidemiology, and molecular biology.

The scientist's work centers on key topics such as immune cell function and interaction, lymphoma diagnosis and treatment, viral-associated cancers and disorders, T-cell and B-cell immunology, cytomegalovirus and herpesvirus research, systemic lupus erythematosus research, and CAR-T cell therapy research.

Frequent co-authors collaborating with Edward H. Giannini include Jesús Merino, Ester Molina, Lucia García-Gutiérrez, Vanessa Junco, and Mercedes Pérez-Olivares. These collaborations highlight a concentrated effort in immunological and oncological research fields.

Edward H. Giannini has published regularly in several scientific journals. Their frequent publication venues are:

  • Frontiers in Immunology
  • The Journal of Immunology
  • Oncogene
  • Journal for ImmunoTherapy of Cancer
  • Arthritis & Rheumatology

Selected recent papers by Edward H. Giannini include:

  • "Multifaceted effects of soluble human CD6 in experimental cancer models," 2020, Journal for ImmunoTherapy of Cancer
  • "MYC directly transactivates CR2/CD21, the receptor of the Epstein-Barr virus, enhancing the viral infection of Burkitt lymphoma cells," 2023, Oncogene
  • "CD38 Deficiency Ameliorates Chronic Graft-Versus-Host Disease Murine Lupus via a B-Cell-Dependent Mechanism," 2021, Frontiers in Immunology
  • "Therapeutic Effects of Anti-Bone Morphogenetic Protein and Activin Membrane-Bound Inhibitor Treatment in Psoriasis and Arthritis," 2020, Arthritis & Rheumatology
  • "INPP5K controls the dynamic structure and signaling of wild-type and mutated, leukemia-associated IL-7 receptors," 2023, Blood

Best Publications

  • Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States

    Reva C. Lawrence;Charles G. Helmick;Frank C. Arnett;Richard A. Deyo

  • Etanercept in Children with Polyarticular Juvenile Rheumatoid Arthritis

    Daniel J. Lovell;Edward H. Giannini;Andreas Reiff;Gail D. Cawkwell

  • Preliminary definition of improvement in juvenile arthritis

    Edward H. Giannini;Nicolino Ruperto;Angelo Ravelli;Daniel J. Lovell

  • Adalimumab with or without Methotrexate in Juvenile Rheumatoid Arthritis

    Daniel J. Lovell;Nicolino Ruperto;Steven Goodman;Andreas Reiff

  • Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial

    Nicolino Ruperto;Daniel J Lovell;Pierre Quartier;Eliana Paz

  • American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis

    Carol A. Wallace;Edward H. Giannini;Bin Huang;Lukasz Itert

  • A randomized, placebo‐controlled trial of infliximab plus methotrexate for the treatment of polyarticular‐course juvenile rheumatoid arthritis

    Nicolino Ruperto;Daniel J. Lovell;Ruben Cuttica;Nick Wilkinson

  • Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis

    Daniel J. Lovell;Andreas Reiff;Andreas Reiff;Norman T. Ilowite;Carol A. Wallace

  • Trial of Early Aggressive Therapy in Polyarticular Juvenile Idiopathic Arthritis

    Carol A. Wallace;Edward H. Giannini;Steven J. Spalding;Philip J. Hashkes;Philip J. Hashkes

  • International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease.

    D. A. Isenberg;E. Allen;V. Farewell;M. R. Ehrenstein

  • Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: interim results from an ongoing multicenter, open-label, extended-treatment trial.

    Daniel J. Lovell;Edward H. Giannini;Andreas Reiff;Olcay Y. Jones

  • Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome

    Joyce Villanueva;Susan Lee;Edward H Giannini;Thomas B Graham

  • Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies: II. The Childhood Myositis Assessment Scale (CMAS): A quantitative tool for the evaluation of muscle function

    Daniel J. Lovell;Carol B. Lindsley;Robert M. Rennebohm;Susan H. Ballinger

  • Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathies

    Lisa G. Rider;Deloris Koziol;Edward H. Giannini;Minal S. Jain

  • Selective accumulation of the first component of complement and leukocytes in ischemic canine heart muscle. A possible initiator of an extra myocardial mechanism of ischemic injury.

    Roger D. Rossen;Judith L. Swain;Lloyd H. Michael;Suzanne Weakley

  • Patterns of clinical remission in select categories of juvenile idiopathic arthritis.

    Carol A. Wallace;Bin Huang;Marcia Bandeira;Angelo Ravelli

  • Long-term safety and efficacy of abatacept in children with juvenile idiopathic arthritis.

    Nicolino Ruperto;Daniel J. Lovell;Pierre Quartier;Eliana Paz

  • Long-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritis.

    Daniel J. Lovell;Andreas Reiff;Olcay Y. Jones;Rayfel Schneider

  • Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis

    Nicolino Ruperto;Angelo Ravelli;Kevin J. Murray;Daniel J. Lovell

  • Long-term safety and effectiveness of etanercept in children with selected categories of juvenile idiopathic arthritis.

    E. H. Giannini;N. T. Ilowite;D. J. Lovell;C. A. Wallace

Frequent Co-Authors

Daniel J. Lovell
Daniel J. Lovell Cincinnati Children's Hospital Medical Center
Nicolino Ruperto
Nicolino Ruperto Istituto Giannina Gaslini
Alberto Martini
Alberto Martini University of Genoa
Angelo Ravelli
Angelo Ravelli University of Genoa
Lisa G. Rider
Lisa G. Rider National Institutes of Health
Lauren M. Pachman
Lauren M. Pachman Northwestern University
Earl D. Silverman
Earl D. Silverman University of Toronto
Frederick W. Miller
Frederick W. Miller National Institutes of Health
Fred D. Finkelman
Fred D. Finkelman University of Cincinnati
Susan D. Thompson
Susan D. Thompson Cincinnati Children's Hospital Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in medicine but seeking flexible study options, online nursing degrees and related programs offer valuable alternatives. Today, many universities provide pathways that are fully online, making it easier for working professionals or those balancing family commitments.

One popular option is enrolling in most affordable online nurse practitioner programs. These programs allow nurses to expand their qualifications and advance their careers. If you are just beginning your journey, exploring nursing school online can help you start in the healthcare field with convenience and cost-effectiveness.

Nurses aiming for leadership or research positions may consider online PhD programs in nursing, which provide advanced knowledge without the need to relocate or pause your career. Alternatively, registered nurses can upgrade their credentials through what is the cheapest rn to bsn program online options, helping improve their job prospects and earning potential.

Exploring these online degrees gives aspiring healthcare professionals an adaptable route to achieve their career goals in the medical field.

Best Scientists Citing Edward H. Giannini

Trending Scientists

Recently Published Articles